相关实验视频
Updated: Sep 14, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
369
推进MSC疗法:下一代强大的介质干细胞用于系统性自身免疫性类风湿性疾病
Hulya Bukulmez1, Kristin B Highland2, Rujman Khan3
1Division of Pediatric Rheumatology, Department of Pediatrics, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Best practice & research. Clinical haematology
|July 23, 2025
概括
介质细胞 stromal 细胞 (MSCs) 显示出治疗系统性自身免疫性类风湿性疾病的前景,这些疾病对标准护理无反应. 最近的临床试验强调了它们在风湿病学,胃肠病学和内分泌学方面的潜在有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 在瘤学瘤学.
背景情况:
- 系统性自身免疫性疾病利用来自瘤学的免疫调节原则.
- 化学抗原受体T (CAR-T) 细胞在瘤学中主导细胞治疗的疗效.
- 介酶体 stromal 细胞 (MSCs) 在瘤学方面取得了有限的成功.
研究的目的:
- 审查MSC在全身性自身免疫性类风湿性疾病中的最近临床试验.
- 突出表明MSC对标准护理 (SOC) 耐药患者的有希望的MSC结果.
主要方法:
- 审查最近的临床试验涉及MSCs.
- 专注于患有系统性自身免疫性类风湿性疾病的患者.
主要成果:
- 多重复合体显示出有前途的治疗潜力.
- 在SOC疗法失败的自身免疫性疾病患者中观察到的有效性.
结论:
- 多重复合体为系统性自身免疫性类风湿性疾病提供了潜在的新疗法.
- 对自身免疫性疾病进行更多的MSC研究是有必要的.
关键词:
细胞疗法是一种细胞疗法.结合性组织疾病 结合性组织疾病免疫调节是一种免疫调节.狼是一种狼.介质细胞干细胞 介质细胞干细胞介质细胞层细胞是介质细胞层细胞.混合结合组织疾病混合结合组织疾病.类风湿性关节炎 类风湿性关节炎 类风湿性关节炎脊髓硬化症是什么 脊髓硬化症斯约格伦病 (Sjogren's disease) 是一种疾病.斯乔格伦综合征 (Sjogren's Syndrome) 是一种疾病,系统性自身免疫性类风湿性疾病.系统性红血性狼 (Systemic lupus erythematosusus) 是一种全身性狼.系统性硬化症 系统性硬化症这是一种I型干扰素.第二种类型的干扰素干扰素.血管炎是一种血管炎.相关概念视频
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Autoimmune Disorders
677
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
677
Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K

